NMRA — NEUMORA THERAPEUTICS INC.
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 118 SEC-registered investment managers reported holding NMRA (NEUMORA THERAPEUTICS INC.) in their latest 13F filings, with a combined reported value of $139.89M across 82.12M shares. That is +9.9% by share count (+6.49M shares) versus the previous quarter, while reported value moved -3.8%. Ownership is concentrated: the five largest holders account for 38.3% of reported value and the top ten for 58.0%.
Compared with the prior quarter, 31 opened new positions, 38 added to existing stakes, 24 trimmed, 29 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of NEUMORA THERAPEUTICS INC. (NMRA) include Capital International Investors, Hillhouse Capital (HHLR Advisors), Artal Group S.A., ranked by reported 13F value among the 278 institutional holders on this page.
NMRA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 83 | 59.89M | $35.90M | +9.8% |
| Q2 2026 | 118 | 82.12M | $139.89M | +9.9% |
| Q1 2026 | 116 | 75.40M | $147.03M | -2.6% |
| Q4 2025 | 105 | 69.41M | $124.24M | +16.9% |
| Q3 2025 | 95 | 56.87M | $103.49M | -6.1% |
| Q2 2025 | 98 | 61.20M | $44.92M | -13.2% |
| Q1 2025 | 116 | 70.38M | $70.35M | -4.3% |
| Q4 2024 | 145 | 80.83M | $855.60M | +5.1% |
Over the 8 quarters shown, institutional share counts decreased 26% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (+16.9%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 8.50M | $5.07M | 0.12% | Hold | |
| 8.14M | $4.85M | 0.00% | Add | |
| 4.67M | $2.78M | 0.00% | Hold | |
| 4.50M | $2.68M | 0.12% | Add | |
| 4.46M | $2.66M | 0.57% | Hold | |
| 4.22M | $2.51M | 0.01% | Hold | |
| 3.31M | $1.97M | 0.02% | Hold | |
| 2.80M | $1.67M | 0.00% | Add | |
| 2.60M | $1.55M | 0.00% | Reduce | |
| 2.12M | $1.27M | 0.18% | Hold | |
| 1.85M | $1.10M | 0.14% | Hold | |
| 1.71M | $1.02M | 0.00% | Add | |
| 1.13M | $673.55K | 0.00% | Reduce | |
| 961.70K | $573.17K | 0.00% | Add | |
| 952.05K | $567.62K | 0.00% | Add | |
| 922.96K | $550.09K | 0.00% | Add | |
| 805.81K | $480.26K | 0.00% | Add | |
| 787.27K | $469.37K | 0.36% | Add | |
| 655.85K | $391.01K | 0.00% | Reduce | |
| 618.36K | $368.67K | 0.01% | Reduce | |
| 557.33K | $332.95K | 0.00% | Reduce | |
| 163.39K | $277.76K | 0.15% | Hold | |
| 404.33K | $241.06K | 0.00% | New | |
| 330.51K | $198.31K | 0.00% | Reduce | |
| 247.54K | $147.59K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 8.50M | $16.57M | 0.46% | Add | |
| 6.09M | $11.88M | 0.10% | Reduce | |
| 5.10M | $9.95M | 0.21% | New | |
| 4.46M | $8.70M | 2.47% | Hold | |
| 4.22M | $8.22M | 0.04% | Hold | |
| 3.89M | $7.59M | 0.00% | New | |
| 3.50M | $6.82M | 0.00% | Hold | |
| 3.31M | $6.45M | 0.08% | Hold | |
| 2.75M | $5.37M | 0.00% | Reduce | |
| 2.75M | $5.37M | 0.01% | Reduce | |
| 2.56M | $4.99M | 0.11% | Hold | |
| 2.12M | $4.14M | 3.44% | Hold | |
| 2.05M | $4.01M | 0.00% | Add | |
| 2.04M | $3.97M | 0.01% | Add | |
| 1.85M | $3.61M | 0.55% | Hold | |
| 1.39M | $2.71M | 0.00% | Reduce | |
| 1.28M | $2.49M | 0.30% | Hold | |
| 1.20M | $2.33M | 0.00% | Add | |
| 1.09M | $2.12M | 0.00% | Add | |
| 1.00M | $1.95M | 0.00% | New | |
| 818.16K | $1.60M | 0.20% | New | |
| 747.66K | $1.46M | 0.00% | Add | |
| 638.78K | $1.25M | 0.03% | Hold | |
| 602.40K | $1.17M | 0.01% | Reduce | |
| 568.28K | $1.11M | 0.00% | Reduce |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.43M | $11.51M | 0.07% | Reduce | |
| 6.29M | $11.26M | 0.34% | Add | |
| 4.54M | $8.13M | 0.00% | Add | |
| 4.46M | $7.98M | 1.81% | Hold | |
| 4.22M | $7.55M | 0.03% | Hold | |
| 3.67M | $6.58M | 0.03% | New | |
| 3.62M | $6.47M | 0.00% | Add | |
| 3.62M | $6.47M | 0.01% | Add | |
| 3.50M | $6.26M | 0.00% | Hold | |
| 3.31M | $5.92M | 0.06% | Hold | |
| 2.56M | $4.58M | 0.07% | Hold | |
| 2.12M | $3.80M | 1.44% | Hold | |
| 2.02M | $3.62M | 0.00% | Add | |
| 1.85M | $3.31M | 0.60% | Hold | |
| 1.45M | $2.59M | 0.00% | Add | |
| 1.31M | $2.34M | 0.01% | Add | |
| 1.28M | $2.29M | 0.27% | Add | |
| 1.08M | $1.94M | 0.00% | Add | |
| 1.00M | $1.80M | 0.00% | Add | |
| 967.24K | $1.73M | 0.09% | Reduce | |
| 858.50K | $1.54M | 0.00% | Add | |
| 638.78K | $1.14M | 0.03% | Hold | |
| 583.76K | $1.04M | 0.00% | New | |
| 572.50K | $1.02M | 0.01% | Add | |
| 534.04K | $956.00K | 0.08% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.54M | $11.90M | 0.05% | Hold | |
| 4.46M | $8.12M | 1.62% | Hold | |
| 4.36M | $7.93M | 0.31% | Hold | |
| 4.22M | $7.67M | 0.03% | Hold | |
| 4.05M | $7.37M | 0.00% | Reduce | |
| 3.50M | $6.37M | 0.00% | Hold | |
| 3.31M | $6.02M | 0.07% | Hold | |
| 2.56M | $4.66M | 0.06% | Hold | |
| 2.12M | $3.87M | 1.75% | Hold | |
| 2.01M | $3.66M | 0.01% | Add | |
| 2.01M | $3.66M | 0.00% | Add | |
| 1.94M | $3.53M | 0.00% | Reduce | |
| 1.85M | $3.37M | 0.67% | Hold | |
| 1.82M | $3.30M | 0.00% | Reduce | |
| 1.40M | $2.55M | 0.10% | Hold | |
| 1.16M | $2.12M | 0.00% | Reduce | |
| 977.00K | $1.78M | 0.00% | Reduce | |
| 968.93K | $1.76M | 0.00% | Add | |
| 830.82K | $1.51M | 0.01% | New | |
| 638.78K | $1.16M | 0.04% | Add | |
| 512.94K | $933.55K | 0.00% | Add | |
| 512.94K | $933.55K | 0.00% | Add | |
| 388.92K | $707.83K | 0.00% | Add | |
| 377.37K | $686.82K | 0.00% | Reduce | |
| 314.12K | $571.70K | 0.00% | Hold |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.54M | $4.80M | 0.02% | Hold | |
| 4.76M | $3.49M | 0.00% | Reduce | |
| 4.46M | $3.27M | 0.64% | Hold | |
| 4.36M | $3.20M | 0.17% | Hold | |
| 4.22M | $3.09M | 0.01% | Hold | |
| 3.50M | $2.57M | 0.00% | Hold | |
| 3.31M | $2.43M | 0.03% | Hold | |
| 2.88M | $2.11M | 0.00% | Reduce | |
| 2.56M | $1.88M | 0.03% | Hold | |
| 2.12M | $1.56M | 0.88% | Hold | |
| 2.10M | $1.54M | 0.00% | Hold | |
| 1.85M | $1.40M | 0.42% | Hold | |
| 1.43M | $1.05M | 0.00% | Add | |
| 1.40M | $1.03M | 0.05% | Hold | |
| 1.23M | $902.98K | 0.00% | Add | |
| 1.23M | $902.98K | 0.00% | Add | |
| 1.23M | $901.30K | 0.00% | Add | |
| 1.03M | $758.67K | 0.01% | Hold | |
| 916.82K | $672.60K | 0.00% | Reduce | |
| 903.74K | $663.00K | 0.05% | Add | |
| 776.07K | $569.09K | 0.00% | Add | |
| 776.07K | $569.09K | 0.00% | Add | |
| 650.70K | $476.97K | 0.00% | Reduce | |
| 588.33K | $431.42K | 0.00% | Add | |
| 502.17K | $368.24K | 0.00% | Reduce |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.61M sh · $4.43M
- ORBIMED ADVISORS LLC 2.14M sh · $3.64M
- Boxer Capital Management, LLC 2.00M sh · $3.40M
- Affinity Asset Advisors, LLC 1.07M sh · $1.82M
- Sixth Street Partners Management Company, L.P. 823.58K sh · $1.40M
- Ensign Peak Advisors, Inc 784.68K sh · $1.33M
- Nuveen, LLC 136.66K sh · $232.33K
- ALLIANCEBERNSTEIN L.P. 110.10K sh · $214.69K
- Deutsche Bank AG 102.15K sh · $173.65K
- Squadron Capital Management LLC 100.00K sh · $170.00K
- PRICE T ROWE ASSOCIATES INC /MD/ 84.16K sh · $144.00K
- Graham Capital Management, L.P. 47.92K sh · $81.46K
Fully Exited (vs previous quarter)
- PERCEPTIVE ADVISORS LLC sold 5.10M sh · $9.95M
- ADAGE CAPITAL PARTNERS GP, L.L.C. sold 1.00M sh · $1.95M
- SILVERARC CAPITAL MANAGEMENT, LLC sold 818.16K sh · $1.60M
- Point72 Asset Management sold 602.40K sh · $1.17M
- Franklin Resources sold 511.08K sh · $996.61K
- TANG CAPITAL MANAGEMENT LLC sold 439.88K sh · $857.76K
- STATE STREET CORP sold 398.72K sh · $777.50K
- HRT FINANCIAL LP sold 198.85K sh · $387.00K
- ExodusPoint Capital Management, LP sold 191.68K sh · $373.77K
- SkyOak Wealth, LLC sold 150.00K sh · $292.50K
- EntryPoint Capital, LLC sold 110.88K sh · $216.21K
- Brevan Howard Capital Management LP sold 97.08K sh · $189.30K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Siren, L.L.C. | 8.50M | 8.50M | 8.50M | 6.29M | 4.36M | 4.36M | 4.36M | 4.40M | 2.61M | — | — | — | — |
| BlackRock Inc | 8.14M | 7.79M | 2.05M | 2.02M | 1.82M | 2.88M | 6.35M | 7.11M | 6.19M | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.67M | 4.67M | 3.89M | — | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 4.50M | 1.07M | — | — | — | — | — | 475.00K | — | — | — | — | — |
| MIC Capital Management UK LLP | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M | 4.46M |
| Exor N.V. | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M | 4.22M |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M | 3.31M |
| Geode Capital Management | 2.80M | 2.61M | 1.09M | 1.00M | 968.93K | 916.82K | 1.98M | 1.97M | 1.98M | 1.29M | 452.38K | 436.88K | 122.19K |
| Fidelity Management & Research (FMR) | 2.60M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 7.84M | 7.75M | 8.62M | 7.48M | 6.37M | 5.62M |
| Lunate Capital Ltd | 2.12M | 2.12M | 2.12M | 2.12M | 2.12M | 2.12M | 2.12M | — | — | — | — | — | — |
| JOHNSON & JOHNSON | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 1.85M | 912.13K |
| STATE STREET CORP | 1.71M | — | 398.72K | 388.92K | 388.92K | 351.25K | 1.72M | 2.06M | 1.79M | 1.08M | 259.18K | 141.48K | — |
| Renaissance Technologies | 1.13M | 1.26M | 1.39M | 1.45M | 1.16M | 1.43M | 1.26M | — | — | — | 138.90K | 13.60K | — |
| UBS Group AG | 961.70K | 143.72K | 59.58K | 94.91K | 129.05K | 650.70K | 3.11M | 12.00K | 339.67K | 295.66K | 25.28K | 256 | — |
| Qube Research & Technologies Ltd | 952.05K | 25.09K | 197.36K | — | — | — | — | — | — | — | 18.24K | — | 21.40K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 922.96K | 894.79K | 184.84K | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 805.81K | 706.67K | 535.03K | — | — | — | — | — | — | — | — | — | — |
| Stonepine Capital Management, LLC | 787.27K | 500.00K | 100.00K | — | — | — | — | — | — | — | — | — | — |
| Ensign Peak Advisors, Inc | 655.85K | 784.68K | — | — | — | — | — | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K |
| AlphaCore Capital LLC | 618.36K | 638.78K | 638.78K | 638.78K | 638.78K | 337.77K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold NMRA?
As of 2026-Q2, 118 institutional funds reported holding NMRA (NEUMORA THERAPEUTICS INC.) in SEC 13F filings, with a combined reported value of $139.89M.
How many shares of NMRA do institutions own?
13F filers reported 82.12M shares of NMRA, worth $139.89M in aggregate at the end of 2026-Q2.
Is institutional ownership of NMRA rising or falling?
Share counts moved +9.9% versus the prior quarter — accumulation.
Who are the top institutional holders of NMRA?
The largest 13F holders are Capital International Investors, Hillhouse Capital (HHLR Advisors), Artal Group S.A., EcoR1 Capital, LLC, Deep Track Capital, LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of NEUMORA THERAPEUTICS INC.?
The major shareholders of NEUMORA THERAPEUTICS INC. (NMRA) by reported 13F value are Capital International Investors, Hillhouse Capital (HHLR Advisors), Artal Group S.A., EcoR1 Capital, LLC, Deep Track Capital, LP, among 278 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.